Sex differences in adverse events in Medicare individuals ≥ 66 years of age post glioblastoma treatment
ConclusionsSex differences for individuals, 66 years and older, diagnosed with GB exist in treatment received and adverse events developed across different treatment modalities.
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research
More News: Brain | Brain Cancers | Brain Tumor | Cancer & Oncology | Chemotherapy | Gastroenterology | Medicare | Neurology | Neurosurgery | Toxicology